| Literature DB >> 29455214 |
Abstract
Bariatric surgery has been considered as an effective treatment for morbid obesity. Apart from procedures related complications, a broad spectrum of neurological disorders affecting any part of neuraxis has been reported following BS. Central nervous system complications, although less common than peripheral nervous system complications, carry significant morbidity and potential mortality. Encephalopathy, behavioral and psychiatric disorders, myelopathy and optic neuropathy are the most frequently reported CNS complications. Early detection and prompt management may improve or completely reverse these neurological complications. It is essential that the treating physicians must be aware of their clinical manifestations and management, so early diagnosis and treatment can prevent patients from suffering significant neurological deficits and even death. This review discusses the clinical manifestations of these complications in detail which will help concerned physician in earlier recognition and hence prevent the delay in specific treatment.Entities:
Mesh:
Year: 2018 PMID: 29455214 PMCID: PMC6751905 DOI: 10.17712/nsj.2018.1.20170316
Source DB: PubMed Journal: Neurosciences (Riyadh) ISSN: 1319-6138 Impact factor: 0.906
Central nervous system complications following bariatric surgery.
| Major disorders | Recognized complications |
|---|---|
| Encephalopathy | Wernicke’s encephalopathy (WE) |
| Encephalopathy associated with D-lactic acidosis | |
| • Hyperammonemic encephalopathy | |
| Neuropsychiatric disorders | • Frank eating disorders |
| • Anorexia nervosa | |
| • Bulimia nervosa | |
| • Binge eating behavior | |
| • Eating avoidance disorder | |
| • Suicide | |
| Myelopathy | • Posterolateral myelopathy |
| • Myeloneuropathy | |
| Optic neuropathy | • Nutritional optic neuropathy |
| Other possible conditions (need to be verified by further studies) | • Stroke and Seizures |
| • CNS demyelination | |
| • Spontaneous intracranial hypotension | |
| • Cognitive impairment secondary to focal brain atrophy |
CNS - central nervous system
Central Nervous System complication and associated micronutrient.
| Conditions | Micronutrient involved and likely pathology |
|---|---|
| Wernicke’s encephalopathy | Thiamin (Vitamin B1) deficiency |
| Episodic encephalopathy | Elevated D-lactate |
| Hyperammonemic encephalopathy (HAE) | Elevated serum ammonia and plasma glutamine levels |
| Zinc deficiency | |
| Underlying Urea cycle disorder | |
| Myelopathy | Cobalamin (Vitamin B12) and Copper deficiency |
| Vitamin E, folate and B6 deficiency (less common) | |
| Optic Neuropathy | Cobalamin (Vitamin B12) deficiency |
| Vitamin A, Copper and zinc deficiency (less common) | |
| Spontaneous intracranial hypotension | Vitamin A and D deficiency |
| Spontaneous CSF leakage |
CSF - cerebrospinal fluid
Diagnosis and treatment of common central nervous system complications.
| Complications | Diagnosis | Treatment |
|---|---|---|
| Wernicke’s encephalopathy | Clinical | Intravenous thiamine 500 mg 3 times a day for 2-3 days followed by 250 mg daily for 3-5 days. |
| Erythrocyte transketolase activation assay or RBC thiamine diphosphate | Oral maintenance dose of 50-100 mg daily for long term | |
| Characteristic paraventricular signals on MRI | ||
| Encephalopathy associated with D-lactic acidosis: | Elevated D- lactate levels in serum and urine | Correction of metabolic acidosis |
| High an ion gap metabolic acidosis | Carbohydrate restriction | |
| Antibiotics | ||
| Hyperammonemic encephalopathy (HAE) | Measurement of plasma ammonia, zinc, glutamine and serum albumin level along with genetic testing for OTC enzyme deficiency | Dietary protein restriction Parenteral glucose and lipid infusion |
| Repletion of zinc, other micronutrients and amino acids. | ||
| Hemodialysis | ||
| Reversal of surgical procedure | ||
| Myelopathy secondary to vitamin B12 deficiency | Serum B12, methylmalonic and plasma homocysteine levels | Intramuscular 1000 mic gram daily for 7 days followed by once weekly and then monthly |
| Abnormal signals in dorsal column and corticospinal tract on MRI | ||
| Myelopathy secondary to copper deficiency | Serum and urinary copper | Parenteral; intravenous 2 mg daily of elemental copper for 5 days |
| Serum ceruloplasmin activity | Oral; 8 mg per day of elemental copper for 1st week, 6 mg for 2nd week, 4 mg for 3rd week and 2 mg thereafter | |
| MRI findings similar to B12 deficiency | ||
| Myelopathy secondary to folate deficiency | RBCs folate | Parenteral; 1-5 mg daily |
| Oral; 1 mg 3 times a day then maintenance dose of 1 mg per day |
RBC - red blood cells, MRI - Magnetic resonance imaging, HAE - Hyperammonemic encephalopathy, OTC - Ornithine transcarbamylase